Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Authors

Keywords

Aromatase inhibitor, Exemestane, Endometrial cancer, Treatment, Phase II study

Journal

Volume 14, Issue 1, Pages -

Publisher

Springer Nature

Online

2014-02-06

DOI

10.1186/1471-2407-14-68

References

View 5 related references

Contact the author

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started